The Dongguan Intermediate People’s Court in southern China has ordered a freeze on 2.14 billion yuan (about US$318 million) in equity interests of Nexperia’s Chinese subsidiaries. This move shields local assets from transfer or collateral use while underscoring the growing operational divide between Nexperia’s China-based manufacturing operations and its European leadership amid a protracted legal fight with Wingtech.
- Court freezes $318 million in Nexperia China assets until 2029
- Legal battle between Wingtech and Nexperia isolates China operations
- China plants shift to domestic suppliers amid supply disruptions
What happened
A Chinese court in Guangdong province has blocked equity interests worth 2.14 billion yuan (around US$318 million) in four Nexperia subsidiaries, including those operating major assembly and test facilities in Dongguan. Additionally, assets tied to Itec BV, a chip tool spin-off from Nexperia, have been frozen. The frozen assets are protected from being transferred or used as collateral for a period of three years until August 2029.
This legal action was prompted by a lawsuit from Wingtech, which claims control over Nexperia and demands 8 billion yuan (US$1.17 billion) in damages under China’s anti-foreign sanctions law. The case follows a series of court rulings and interventions involving both Chinese and Dutch courts, with Wingtech battling for influence over Nexperia after state and corporate interventions split the company’s China and European operations.
Why it matters
The asset freeze effectively entrenches the operational independence of Nexperia’s Chinese manufacturing base from its European headquarters. This split has disrupted supply chains, such as cutting wafer deliveries from Nexperia facilities in Germany and the UK to the Dongguan plant, forcing a pivot to domestic suppliers and underscoring increasing self-reliance amid geopolitical and legal pressures.
For Wingtech, the legal and operational turmoil has translated into steep financial losses, including a 189 million yuan net loss in Q1 2026, following a larger loss in 2025. The company also faces potential delisting due to auditor concerns about verifying overseas financial data, which compounds the uncertainty around the semiconductor joint venture’s future and the broader China tech supply ecosystem.
What to watch next
The ongoing litigation between Wingtech and Nexperia will be critical to monitor, as the court freeze could be lifted or extended depending on legal outcomes, which remain uncertain and potentially protracted. The intermediate court’s ruling is expected several months after hearings begin, but appeals could extend the timeline to years, keeping operational and financial risk high for involved parties.
Meanwhile, Nexperia’s efforts to fully localize its Chinese operations and supply chain will be a key indicator of how the semiconductor manufacturer plans to navigate geopolitical friction and maintain production capacity. In parallel, Wingtech’s ability to resolve auditor concerns and stave off delisting amid significant net losses will be important signals of its financial health and strategic direction.